Clinical trials
Terminated Phase 3 Glucose Metabolism Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 3 |
| 2004 | 2 |
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 6 |
| Denver Health and Hospital Authority | 1 |
| Orexigen Therapeutics, Inc | 1 |
| Rabin Medical Center | 1 |
| Solvay Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Metabolism Disorders | 10 |
| Diabetes Mellitus | 9 |
| Diabetes Mellitus, Type 2 | 8 |
| Dyslipidemias | 7 |
| Diabetes Mellitus, Lipoatrophic | 6 |
| Endocrine System Diseases | 3 |
| Metabolic Diseases | 3 |
| Cardiovascular Diseases | 2 |
| Heart Diseases | 2 |
| Body Weight | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.